Scientists at the Stanford University School of Medicine identified a previously unsuspected job performed by the enzyme, ALDH1a1, in mice.
Jun Ding, assistant professor of neurosurgery and his colleagues showed that blocking ALDH1a1 activity caused mice's consumption of and preference for alcohol to rise to levels equivalent to those observed in mice that had experienced several rounds of the equivalent of binge drinking.
Restoring ALDH1a1 levels reversed this effect.
A key finding in the new study is that in certain nerve cells strongly implicated in addictive behaviours, ALDH1a1 is an essential piece of a previously unknown biochemical assembly line for the manufacture of an important neurotransmitter called GABA.
While GABA is produced widely throughout the brain, the novel GABA-production assembly line identified by Ding's group was observed only in a group of nerve cells known to play a powerful role in addiction.
The new finding has potentially great clinical significance because a drug that could increase GABA synthesis through this alternative assembly line - by boosting ALDH1a1 levels in the brain - could potentially restore the balance in neural circuitry that's been thrown out of kilter by excessive alcohol consumption without dangerously elevating GABA levels elsewhere in the brain.
Ding did a literature search to see how biological systems manufacture GABA. He learned that in plants, GABA can be produced via a biochemical assembly line quite separate from the common, previously known one our brains use.
He found that one step in this alternative GABA-manufacturing pathway is performed by a family of enzymes, aldehyde dehydrogenases, that are better known for being involved in the breakdown of alcohol.
Ding's team verified that the specific family member at work in those dopamine-producing cells was ALDH1a1.
In behavioural tests, the ALDH1a1-deficient mice showed the same increased alcohol preference and intake as did otherwise normal "binge-drinker" mice. These effects were reversed by manipulations that raised ALDH1a1 levels in the mice.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
